ArticleAmerican health & drug benefits

Economic Implications of Preventing Major Cardiovascular and Limb Events with Rivaroxaban plus Aspirin in Patients with Coronary or Peripheral Artery Disease in the United States.

Luis Hernandez et al.PubMed ↗Full text ↗

No numbers read from the abstract.